Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 150,164 | 198,955 | 55,843 | 58,206 | 227,035 |
| Marketable Securities | 887,152 | 862,941 | 900,163 | 980,191 | 1,118,847 |
| Receivables | 29,156 | 38,889 | 42,925 | 47,245 | 42,031 |
| Inventories | 16,808 | 15,292 | 12,892 | 12,584 | 14,320 |
| Other current assets | 15,771 | 21,928 | 32,033 | 53,742 | 27,091 |
| TOTAL | $1,099,051 | $1,138,005 | $1,043,856 | $1,151,968 | $1,429,324 |
| Non-Current Assets | |||||
| PPE Net | 58,510 | 59,662 | 60,189 | 61,372 | 62,307 |
| Investments And Advances | 96,093 | 136,662 | 197,715 | 172,166 | 185,900 |
| Intangibles | 76,501 | 76,501 | 76,501 | 76,501 | 76,501 |
| Other Non-Current Assets | 126,406 | 127,937 | 130,405 | 132,871 | 133,901 |
| TOTAL | $357,510 | $400,762 | $464,810 | $442,910 | $458,609 |
| Total Assets | $1,456,561 | $1,538,767 | $1,508,666 | $1,594,878 | $1,887,933 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 254,144 |
| Accounts payable and accrued liabilities | 22,434 | 22,139 | 15,484 | 19,246 | 21,789 |
| Accrued Expenses | 70,598 | 58,739 | 85,531 | 76,392 | 69,615 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,459 |
| TOTAL | $123,633 | $115,779 | $126,500 | $123,958 | $377,471 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 507 | 1,757 | 3,007 |
| Other Non-Current Liabilities | 338,422 | 345,693 | 208,691 | 212,156 | 211,482 |
| TOTAL | $338,422 | $345,693 | $211,185 | $214,680 | $214,036 |
| Total Liabilities | $462,055 | $461,472 | $337,685 | $338,638 | $591,507 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,160 | 12,152 | 11,966 | 11,933 | 11,872 |
| Common Shares | 18 | 18 | 18 | 18 | 17 |
| Retained earnings | -2,432,125 | -2,309,158 | -2,191,955 | -2,083,369 | -2,003,369 |
| Other shareholders' equity | -3,121 | -2,295 | -1,080 | 715 | -6,877 |
| TOTAL | $994,506 | $1,077,295 | $1,170,981 | $1,256,240 | $1,296,426 |
| Total Liabilities And Equity | $1,456,561 | $1,538,767 | $1,508,666 | $1,594,878 | $1,887,933 |